{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-281051","form_type":"8-K","ticker":"KYMR","cik":"0001815442","company_name":"Kymera Therapeutics, Inc.","filed_at":"2026-06-24T20:07:58+00:00","discovered_at":"2026-06-24T20:09:00.299578+00:00","generated_at":"2026-06-24T20:09:27.141040+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Kymera annual meeting results: all Class III directors elected, say-on-pay approved, EY ratified","bullets":["Elected Bruce Booth, Nello Mainolfi, John Maraganore, Elena Ridloff as Class III directors for 3-year terms.","Advisory vote on named executive officer compensation passed with 74.9M for, 2.5M against, 26.6K abstain.","Ratified Ernst & Young as independent auditor for FY2026 with 79.0M for, 38.1K against, 18.2K abstain."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-281051","json":"https://secwatch.observer/filing/0001193125-26-281051.json","markdown":"https://secwatch.observer/filing/0001193125-26-281051.md","text":"https://secwatch.observer/filing/0001193125-26-281051.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1815442/000119312526281051/0001193125-26-281051-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1815442/000119312526281051/d131538d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T20:09:27.141040+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}